alliance trials: combination of modified folfirinox and radiotherapy for pancreatic cancer
Published 1 year ago • 430 plays • Length 4:04Download video MP4
Download video MP3
Similar videos
-
1:38
nepafox: adjuvant gemcitabine vs. folfirinox in resectable pancreatic cancer
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer
-
3:03
the future of radiotherapy as a treatment for pancreatic cancer
-
1:15
optimizing first line treatment in metastatic pancreatic cancer
-
0:42
folfirinox, gemcitabine paclitaxel to enhance surgery outcomes for locally advanced pc
-
1:15
proton-panc: proton therapy in adjuvant pancreatic cancer
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
1:58
gemcitabine-based chemotherapy after folfirinox in advanced pancreatic cancer
-
3:39
a phase ib study folfirinox and nis793 in patients with pancreatic cancer
-
2:49
addition of salmonella-il2 to folfirinox for metastatic stage 4 pc nearly doubles median survival
-
12:08
pancreatic cancer debate: optimal therapy - adjuvant folfirinox
-
5:16
[pancreas] preoperative mfolfirinox vs chemoradiation, who wins?
-
15:55
improving the outcome of patients with metastatic pancreatic cancer
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
0:53
rationale for locally aggressive treatment of pancreatic cancer
-
0:16
dr. weinberg discusses the use of folfirinox in older patients with metastatic pancreatic cancer
-
16:40
radiation treatment and pancreatic cancer: when, how, and why?
-
7:54
pancreatic cancer debate: optimal therapy - preoperative chemo/chemoradiotherapy
-
36:41
icaho20 - asco direct™ highlights - dr. andrew coveler - pancreatic cancer